Human Genetics Laboratory, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Molecular and Cellular Biology Graduate Program (PPGBMC), Federal University of the State of Rio de Janeiro (UNIRIO), Rio de Janeiro, Brazil.
Mol Genet Genomic Med. 2019 Jul;7(7):e00645. doi: 10.1002/mgg3.645. Epub 2019 Jun 14.
Cystic fibrosis (CF) is caused by mutations in the cystic fibrosis transmembrane conductance regulator gene (CFTR). There are over 2000 different pathogenic and non-pathogenic variants described in association with a broad clinical heterogeneity. The most common types of mutations in this gene are single nucleotide substitutions or small deletions and insertions. However, large rearrangements, such as large duplications or deletions, are also a possible cause of CF; these variations are rarely tested in routine screenings, and much of them remain unidentified in some populations, especially those with high ethnic heterogeneity.
The present study utilized the Multiplex Ligation-dependent Probe Amplification (MLPA) technique for the detection of duplications and deletions in 165 CF patients from the Rio de Janeiro State (Brazil), which after extensive mutational screening, still exhibited one or two unidentified CF alleles.
Five patients with alterations in MLPA signals were detected. After validation, we identified three copy number variations, one large duplication (CFTRdup2-3) and two large deletions (CFTRdel25-26 and CFTRdel25-27-CTTNBP2). Two detected deletions were not validated. They were false positives caused by a small deletion of 18 base pairs (232del18) and a point mutation (S168L) in the probe binding site.
Our results highlight the importance of screening for large rearrangements in CF cases with no or only one CFTR mutation defined.
囊性纤维化(CF)是由囊性纤维化跨膜电导调节因子(CFTR)基因突变引起的。与广泛的临床异质性相关,已有超过 2000 种不同的致病性和非致病性变体被描述。该基因中最常见的突变类型是单核苷酸取代或小的缺失和插入。然而,大的重排,如大片段重复或缺失,也是 CF 的一个可能原因;这些变异在常规筛查中很少被检测到,而且在一些人群中,尤其是那些具有高度种族异质性的人群中,许多变异仍然未被识别。
本研究采用多重连接依赖性探针扩增(MLPA)技术检测了来自巴西里约热内卢州的 165 名 CF 患者的重复和缺失情况,这些患者在经过广泛的突变筛查后,仍然存在一个或两个未识别的 CF 等位基因。
检测到 5 名 MLPA 信号改变的患者。经过验证,我们确定了三种拷贝数变异,一种大片段重复(CFTRdup2-3)和两种大片段缺失(CFTRdel25-26 和 CFTRdel25-27-CTTNBP2)。两个检测到的缺失未被验证。它们是由 18 个碱基对(232del18)的小缺失和探针结合位点的点突变(S168L)引起的假阳性。
我们的结果强调了在只有一个或没有明确的 CFTR 突变的 CF 病例中筛查大重排的重要性。